PRESENTATION FORMATS
Plenary Lectures will provide updates on the main topics of the meeting.
State of the Art Lectures will illustrate the current standard of knowledge in basic and clinical research.
Oral presentations – selected abstracts with will be presented as short reports within
10 minutes.
Poster presentations - Posters will be on display from Thursday, May 14, 2009 to Sunday, May 16, 2009. The presenting authors should be available for explanation and discussion during the morning, 10:30–11:00 hrs and afternoon, 16:45–17:15 hrs breaks.
Helmut Vinazzer award - Scientific Committee will select the best poster presentation and award the first author.
SCIENTIFIC SESSIONS
Downlad Final ProgrammePLENARY LECTURES
|
Sam Schulman
McMaster University, Department of Medicine, Hamilton, ON, Canada The old versus the new in anticoagulation for venous thromboembolism |
|
Igor N. Bokarev, Ljudmila V. Popova
How to use DIC diagnosis today?
|
|
Helmut Sinzinger1, Ernst Ruppert1, Herbert Laimer2 1Institute for Diagnosis and Treatment of Atherosclerosis and Lipid Disorders (ATHOS), Vienna, Austria; 2Rehabilitation Center Bad Tatzmannsdorf, Austria Is lipoprotein (a) regulating the prostaglandin I2-synthesis stimulating plasma factor? |
|
Christopher A. Ludlam
Haemophilia & Thrombosis Comprehensive Care Centre, Royal Infirmary of Edinburgh, UK Haemophilia care in Europe – how can we improve it? |
|
Flora Peyvandi
Angelo Bianchi Bonomi Hemophilia and Thrombosis Centre, University of Milan, Department of Medicine and Medical Specialities, IRCCS Maggiore Hospital, Mangiagalli and Regina Elena Foundation, Luigi Villa Foundation, Milan, Italy Obstetric and gynecological problems in women with inherited bleeding disorder |
STATE OF THE ART LECTURES
|
Nebojsa Antonijevic1, N. Radovanovic1, M. Kocica1 D. Mikovic2, M. Kovac2, S. Tadic2, I. Antonijevic2, S. Draskovic2, V. Djordjevic3, B. Stojanovic1, S. Obradovic4, B. Calija5, J. Perunicic1, B. Terzic1 1Institute of Cardiovascular Diseases, Clinical Center of Serbia; 2Blood Transfusion Institute of Serbia; 3Institute of Molecular Genetics and Genetic Engineering; 4Clinic of Urgent Medicine, Military Medical Academy; 5Institute of Cardiovascular Diseases Dedinje, Belgrade, Serbia Obstacles in diagnostics and therapy of heparin-induced thrombocytopenia |
|
Ljudmila Stojanovic1, I. Elezovic2, D. Marisavljevic1, D. Petrovic3, Z. Mikovic4, R.Petrovic3, 1Internal Medicine, “Bezanijska Kosa” University Medical Center, 2Institute of Hematology, 3Institute of Rheumatology, 4Clinic of Gynecology and Obstetrics “Narodni Front”, Belgrade Serbia;5Health Center Sabac Thrombosis in antiphospholipid syndrome: results from the Serbian national APS Registry |
|
Aleksandra Antovic1, Nils Hakan Wallen1, Fariborz Mobarrez1, Gun Jorneskog1, Shu He1,2, Margareta Blomback2 1Department of Clinical Sciences, Danderyd Hospital, 2Coagulation Research, Dept Molecular Medicine & Surgery, Karolinska University Hospital, all from Karolinska Institutet, Stockholm, Sweden Factors influencing fibrin structure and function. relevance to clinical disease |
|
F. Mobarrez1, N. H. Wallen1, N. Egberg 2, G. Jorneskog 1, M. Hansson3, Jovan P. Antovic2 1Karolinska Institutet, Department of Clinical Sciences, Danderyd Hospital, Divisions of Internal and Cardiovascular Medicine 2Karolinska Institutet, Department of Molecular Medicine & Surgery, Coagulation Research & Clinical Chemistry, Karolinska University Hospital Solna 3Karolinska Institutet, Department of Medicine, Clinical Allergy Research Unit, Clinical Immunology, Karolinska University Hospital Solna How to measure platelet microparticles using flow-cytometry? |
|
Mojca Stegnar
University Medical Centre Ljubljana, Department of Vascular Diseases, Ljubljana, Slovenia Platelet function tests and resistance to antiplatelet therapy |
|
Federico Fernandez-Palazzi, Manuel Cedeno, Absara Boadas, Arlette Saez, Orthopaedic Unit. National Haemophilia Center, Caracas, Venezuela How safe is radioctive synoviorthesis in haemophilia |
SATELLITE SYMPOSIA
Bayer Health Care, Bayer Schering Pharma
Recombinant FVIII and hemophilia A
Maria Elisa Mancuso
Usage of rFVIII in children in Italy
Dragana Janic
Experience with rFVIII and prophylaxis in the treatment of patient with severe hemophilia A
Nada Gvozdenovic-Rasovic
First experience with rFVIII in the treatment of patient with severe hemophilia A
Dr Dušan Avramovic
Xarelto – the first oral, direct Factor Xa inhibitor
Siemens Healthcare Diagnostics and Interlab exim
Christine Dahler
- Challenges and benefits of D-dimer testing
- The new INNOVANCE D-Dimer
- State-of-the-art antithrombin testing
Richard Morales
- The Next Generation of Hemostasis Analyzers, The CS-2000i
Novo Nordisk
Guenter Auerswald
Prophylaxis in patients with inhibitors to haemophilia A
Ivo Elezovic
Acquired haemophilia-are we aware enough?
Instrumentation Laboratory
Alberto Strada
Innovation is here – IL proposal to modern coagulation lab
Baxter
Programme will be available quite soon!
Octapharma
Human proteins for human patients
Erling Norrby
The evolutionary chess game between viruses and man
- subcellular infectious agents; viruses, prions and more
Andrea Neisser-Svae
Pathogen inactivation
- The definitive safeguard for plasma
